Back to top
more

Global X Genomics & Biotechnology ETF: (GNOM)

(Real Time Quote from BATS) As of Apr 16, 2024 09:44 AM ET

$10.05 USD

10.05
69,650

-0.20 (-1.95%)

Volume: 69,650

Zacks ETF Rank

This is our ETF rating system that serves as a timeliness indicator for ETFs over the next 6 months:

Zacks Rank Definition
1 Strong Buy
2 Buy
3 Hold
4 Sell
5 Strong Sell

See all the Top Ranked ETFs here - The complete list of all the top ranked ETFs

NA

ETF Quote Details

Previous Close 10.25
Open 10.57
Bid 10.17
Ask 11.35
Day Low-High 10.05-10.57
52wk Low-High 8.63-13.33
Volume 69,650
NAV (month end) 11.36
Premium (+)/Discount (-) (month end)-1.11

Zacks Premium Research for GNOM

Zacks ETF Rank

This is our ETF rating system that serves as a timeliness indicator for ETFs over the next 6 months:

Zacks Rank Definition
1 Strong Buy
2 Buy
3 Hold
4 Sell
5 Strong Sell

See all the Top Ranked ETFs here - The complete list of all the top ranked ETFs

 NA
ETF Risk

Zacks proprietary quantitative models divide each set of ETFs following a similar investment strategy (style box/industry/asset class) into three risk categories- High, Medium, and Low. The aim of our models is to select the best ETFs within each risk category, so that investors can pick an ETF that matches their particular risk preference in order to better achieve their investment goals.

NA
ETF Snapshot

ETF Expense Ratio

Expense Ratio 0.50%
Dividend (Yield) $0.00 (0.00%)
Issuer GLOBAL X MANAGEMENT

Benchmark for GNOM

SOLACTIVE GENOMICS INDEX

The Solactive Genomics Index tracks the companies that generate revenues from gene editing, genomic sequencing, development and testing of genetic medicine/therapies, computational genomics and genetic diagnostics, and biotechnology.

Fund Summary for GNOM

GLOBAL X GENOMICS & BIOTECHNOLOGY ETF

The Global X Genomics & Biotechnology ETF seeks to provide investment results that correspond generally to the price and yield performance, before fees and expenses, of the Solactive Genomics Index.